These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


98 related items for PubMed ID: 12909002

  • 21. Evidence for increased methylglyoxal in the vasculature of women with preeclampsia: role in upregulation of LOX-1 and arginase.
    Sankaralingam S, Xu H, Jiang Y, Sawamura T, Davidge ST.
    Hypertension; 2009 Oct; 54(4):897-904. PubMed ID: 19687346
    [Abstract] [Full Text] [Related]

  • 22. Accumulation of Advanced Glycation End Products Involved in Inflammation and Contributing to Severe Preeclampsia, in Maternal Blood, Umbilical Blood and Placental Tissues.
    Chen W, Zhang Y, Yue C, Ye Y, Chen P, Peng W, Wang Y.
    Gynecol Obstet Invest; 2017 Oct; 82(4):388-397. PubMed ID: 27505171
    [Abstract] [Full Text] [Related]

  • 23. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester].
    Chen Q, Zhao Y, Zou L, Wang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):161-4. PubMed ID: 17537299
    [Abstract] [Full Text] [Related]

  • 24. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
    Rajakumar A, Michael HM, Rajakumar PA, Shibata E, Hubel CA, Karumanchi SA, Thadhani R, Wolf M, Harger G, Markovic N.
    Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
    [Abstract] [Full Text] [Related]

  • 25. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia.
    Laigaard J, Sørensen T, Placing S, Holck P, Fröhlich C, Wøjdemann KR, Sundberg K, Shalmi AC, Tabor A, Nørgaard-Pedersen B, Ottesen B, Christiansen M, Wewer UM.
    Obstet Gynecol; 2005 Jul; 106(1):144-9. PubMed ID: 15994630
    [Abstract] [Full Text] [Related]

  • 26. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Piperi C, Kalofoutis A, Creatsas G.
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):37-43. PubMed ID: 15638868
    [Abstract] [Full Text] [Related]

  • 27. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award.
    Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee Kim Y, Gonçalves LF, Gomez R, Edwin S.
    Am J Obstet Gynecol; 2004 Jun; 190(6):1541-7; discussion 1547-50. PubMed ID: 15284729
    [Abstract] [Full Text] [Related]

  • 28. Altered expression of TCR-CD3zeta induced by sera from women with preeclampsia.
    Whitecar PW, Boggess KA, McMahon MJ, Thorp JM, Taylor DD.
    Am J Obstet Gynecol; 2001 Oct; 185(4):812-8. PubMed ID: 11641657
    [Abstract] [Full Text] [Related]

  • 29. Low plasma levels of oxidized low density lipoprotein in preeclampsia.
    Raijmakers MT, van Tits BJ, Hak-Lemmers HL, Roes EM, Steegers EA, Peters WH.
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1173-7. PubMed ID: 15548151
    [Abstract] [Full Text] [Related]

  • 30. Neutrophil activation and C-reactive protein concentration in preeclampsia.
    Belo L, Santos-Silva A, Caslake M, Cooney J, Pereira-Leite L, Quintanilha A, Rebelo I.
    Hypertens Pregnancy; 2003 Dec; 22(2):129-41. PubMed ID: 12908997
    [Abstract] [Full Text] [Related]

  • 31. Endogenous soluble receptor for advanced glycation endproducts is increased in preeclampsia.
    Fasshauer M, Seeger J, Waldeyer T, Schrey S, Ebert T, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H.
    J Hypertens; 2008 Sep; 26(9):1824-8. PubMed ID: 18698218
    [Abstract] [Full Text] [Related]

  • 32. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia.
    Cotter AM, Molloy AM, Scott JM, Daly SF.
    Am J Obstet Gynecol; 2001 Oct; 185(4):781-5. PubMed ID: 11641651
    [Abstract] [Full Text] [Related]

  • 33. Maternal plasma fibronectin and advanced oxidative protein products for the prediction of preeclampsia in high risk pregnancies: a prospective cohort study.
    Dane C, Buyukasik H, Dane B, Yayla M.
    Fetal Diagn Ther; 2009 Oct; 26(4):189-94. PubMed ID: 19923789
    [Abstract] [Full Text] [Related]

  • 34. Endothelial dysfunction in preeclampsia.
    Roberts JM.
    Semin Reprod Endocrinol; 1998 Oct; 16(1):5-15. PubMed ID: 9654603
    [Abstract] [Full Text] [Related]

  • 35. Soluble receptor for advanced glycation end products in physiological and pathological pregnancy.
    Germanová A, Koucký M, Hájek Z, Parízek A, Zima T, Kalousová M.
    Clin Biochem; 2010 Mar; 43(4-5):442-6. PubMed ID: 19909734
    [Abstract] [Full Text] [Related]

  • 36. Effects of a phosphodiesterase-5 (PDE5) inhibitor on endothelium-dependent relaxation of myometrial small arteries.
    Wareing M, Myers JE, O'hara M, Kenny LC, Warren AY, Taggart MJ, Skillern L, Machin I, Baker PN.
    Am J Obstet Gynecol; 2004 May; 190(5):1283-90. PubMed ID: 15167831
    [Abstract] [Full Text] [Related]

  • 37. Skin autofluorescence as marker of tissue advanced glycation end-products accumulation in formerly preeclamptic women.
    Coffeng SM, Blaauw J, Souwer ET, Rakhorst G, Smit AJ, Graaff R, van Doormaal JJ, Aarnoudse JG, Faas MM, van Pampus MG.
    Hypertens Pregnancy; 2011 May; 30(2):231-42. PubMed ID: 20701478
    [Abstract] [Full Text] [Related]

  • 38. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
    Tanikawa T, Okada Y, Tanikawa R, Tanaka Y.
    J Vasc Res; 2009 May; 46(6):572-80. PubMed ID: 19571577
    [Abstract] [Full Text] [Related]

  • 39. Elevated soluble endothelial cell protein C receptor (sEPCR) levels in women with preeclampsia: a marker of endothelial activation/damage?
    Saposnik B, Peynaud-Debayle E, Stepanian A, Baron G, Simansour M, Mandelbrot L, de Prost D, Gandrille S.
    Thromb Res; 2012 Feb; 129(2):152-7. PubMed ID: 21824644
    [Abstract] [Full Text] [Related]

  • 40. Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia.
    Molvarec A, Szarka A, Walentin S, Beko G, Karádi I, Prohászka Z, Rigó J.
    Clin Chim Acta; 2011 Oct 09; 412(21-22):1957-62. PubMed ID: 21756887
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.